Conclusion-On-site HV measurements showed high variability, but the impact on the eligibility determination was small.
B
ecause of prognostic significance, hematoma volume (HV) 1 is frequently used as 1 of the criteria for enrollment or stratification in clinical trials involving intracerebral hemorrhage (ICH). 2 The ABC/2 method is used for calculating HV, which is based on ellipsoid volume formula. 3, 4 Previous studies have reported good correlation between the ABC/2 method and computer-assisted methods. 3, 5, 6 Kothari et al 3 and Huttner et al 6 reported high correlation between HV values derived from ABC/2 and computer-assisted methods. 3, 6 Sheth et al 5 found that ABC/3 and ABC/2 methods underestimated median HV by 9 (3-28) cm 3 and 4 (0.8-12) cm 3 , respectively, compared with computer-assisted method. 5 However, the reliability of on-site HV measurement using ABC/2 by numerous investigators in multicenter ICH trials has not been evaluated. We analyzed data from a multicenter trial to (1) examine the accuracy of HV measurement using ABC/2 method by multiple investigators and (2) assess the impact of utilizing the ABC/2 method in eligibility determination.
Methods
We analyzed data from the multicenter, open-labeled Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH) trial (ClinicalTrial.gov # NCT00415610). ATACH enrolled 60 subjects with supratentorial ICH and HV <60 cm 32 to determine the tolerability and safety of blood pressure reduction in acute ICH.
On-Site HV Measurement
To determine eligibility, on-site HV was measured by the site investigators using the ABC/2 method on the initial computed tomographic (CT) scan: A, maximum hematoma diameter; B, maximum diameter perpendicular to A; and C, number of slices in vertical plane with hematoma multiplied by slice thickness. 3, 4 The study protocol, which included a description of the ABC/2 method, was available to investigators before trial initiation, but no dedicated training was provided. The ATACH trial did not have specific requirements for CT scan acquisition. Only 2 institutions, which contributed a total of 7 patients, had slice thickness of 4.5 mm; the rest of the CT scans had slice thickness of 5 mm.
HV Measurement at Core Imaging Laboratory
CT scans were sent to the core-imaging laboratory in DICOM format. Blinded imaging analysis was performed using the Medical Image Background and Purpose-The reliability of hematoma volume (HV) measurement using the ABC/2 method in multicenter clinical trials is unknown. We determined the accuracy of ABC/2 method as an on-site test in comparison with the gold standard central HV-assessment and semiautomatic HV-assessment.
Method-We analyzed data from an acute intracerebral hemorrhage multicenter clinical trial. HV was measured by site investigators to determine enrollment eligibility (<60 cm 3 ) using the ABC/2 method (on-site HV), and independently by the core-imaging laboratory using computer-based analysis (Medical Image Processing, Analysis, and Visualization [MIPAV] HV). HV was also measured by ABC/2 method (central HV) at the core-imaging laboratory to assess the difference in measurements between onsite (multiple raters with variable experiences) and central (single experienced rater) HVs.
Results-Fifty-six subjects were analyzed (mean age 62±15 years; 45% women). On-site HV values showed a significantly lower correlation with the MIPAV HV (r=0.63) than central HV and MIPAV HV (r=0.93) values. The correlation between on-site HV and central HV values was modest (r=0.51). A total of 73% of the central HVs were within 25% of the corresponding MIPAV HVs, whereas only 46% of the on-site HVs were within 25% of the corresponding MIPAV HVs (P<0.001). One protocol violation occurred as a result of inaccuracy of on-site HV measurement.
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Processing, Analysis, and Visualization (MIPAV) software (gold standard). This is an imaging analysis software package available online without charge from the National Institutes of Health. 7 The hematoma margins are manually traced on each CT slice. MIPAV software automatically calculated the surface area per slice and the total HV (see Figure I in the online-only Data Supplement).
Central HV Measurement
HV was remeasured using the ABC/2 method independently by one of the authors (H.M.H.), using HV calculator, which calculates HV once the 3 dimensions are entered. 8 Central ABC/2 was performed to (1) differentiate the error attributable to the mathematical limitations of ABC/2 formula and the inaccuracy of on-site ABC/2 attributable to multiple investigators and time sensitive ascertainment; and (2) identify hematoma characteristics that may disproportionately contribute to inaccuracy of on-site ABC/2, including irregularity, heterogeneity, segmentation, and presence of satellite lesions. 
Results
Of the 60 subjects enrolled, 56 were included (mean age 62±15 years; 45% women), whereas 4 were excluded (hard copies 
Discussion
Both on-site ABC/2 and central ABC/2 method overestimated HV, which is in agreement with previous studies. 5 The strong agreement between central ABC/2 and MIPAV (r=0.93) was significantly reduced when the ABC/2 method was used by multiple trial investigators with variable familiarity with the ABC/2 method within the short recruitment time window. The inter-rater reliability in previous studies has ranged from 0.63 to 0.99. 3, 9 The mean difference between central ABC/2 and MIPAV (1 cm 3 ) was smaller than that observed by Hutter et al (4 cm (26 cm 3 ), supporting the concept that the accuracy of ABC/2 method is lower in large ICHs. One study estimated the error of ABC/2 method to be 10% for HV < 20 cm 3 , and 37% for HV > 40 cm 3 . 9 Location (lobar versus deep) was the only morphological characteristic that affected the accuracy of on-site HV measurement, perhaps because of the small sample size or the homogeneity of the sample with specific inclusion/exclusion criteria.
A critical analysis of our data suggested 2 explanations for the differences between on-site and central ABC/2 method: (1) wrong decimal point placement, probably an error in unit conversion from mm to cm, (2) using too few or too many 2s, some on-site HV being exactly half or double the corresponding central HV. This is a common misinterpretation of the ABC/2 formula, in which the denominator of the formula is confused with the denominator used to calculate the C-dimension from 5-mm CT slices. 10 Despite these limitations, on-site ABC/2 was reliable in determining eligibility in the ATACH trial and only led to 1 protocol violation.
In the ongoing phase III ATACH II trial, we addressed the issue of ABC/2 reliability by (1) incorporating ABC/2 method
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training in the educational material of the trial and requiring investigators to pass a test before site initiation, (2) requiring the entry of the 3 hematoma dimensions, not just the total HV, before randomization, ensuring accurate data entry, and (3) providing HV calculator as a mobile application.
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